TGN1412 stimulated the immune system’s T-cells to catastrophic levels; the experiment nearly killed all human subjects. All human subjects in a Phase I drug trial testing a genetically engineered experimental monoclonal antibody drug, TGN1412, face life-threatening multi-organ failure.

Read More